Development of an Online Database of Published Usable Mapping Algorithms Used to Estimate EQ-5D Utilities
Author(s)
Khan I1, Crott R2, Barlas Z3, Rahim H3, Begum R3
1University of Warwick, Coventry, West Midlands, UK, 2Independent Consultant, Colombiers, Charent Maritime, France, 3Regulatory Scientific and Health Solutions, Birmingham, West Midlands, UK
Presentation Documents
OBJECTIVES: Over 200 mapping algorithms have been published that allow for prediction of EQ-5D utilities. A database of usable algorithms is needed to allow researchers and HTA agencies to identify quickly, the quality and suitability of algorithms used. We present a freely available online database of such algorithms across all disease areas, with a classification based on a ‘traffic light’ system of red (warning), amber (use with caution) and green (usable).
METHODS: We searched the available databases (including PubMed, Cochrane Library) to identify all published mapping algorithms and classified them by disease area. We report important metrics including the sample sizes used, the source and quality of data and the reported predictive properties. We classify these using simulation methods across properties and advocate a new classification system of the form:
Pr [(Ωj > 0) |∧, Ai] ≥ Δ , for ∧ ∈ {measures such as R2 , % predicted} Pr [(Ωj < 0) |∧, Aj] ≥ Δ , for ∧ ∈ {measures such as MSE, MAE} Where, Ωj = ( θ*.j - μ), θ*.j is an overall average performance metric and μ is an overall performance measure across algorithms and Ai is each algorithm.RESULTS: We identified over 200 mapping algorithms over 40 disease areas. The most common disease area was Oncology; 60% of algorithms were classified as red (warning); 20% as amber (use with caution) and 20% as green (usable). Identified mapping algorithms included those that predicted EQ-5D utility scores and EQ-5D dimension levels.
CONCLUSIONS: Mapping algorithms can be classified and although the classification approach may require further work, the database offers a rich source of structured information on the use of mapping algorithms consistent with the guidance provided in NICE DSU TSD 22 (June 2023). This will be a valuable resource freely available to academics and pharmaceutical companies for economic evaluation purposes.
Conference/Value in Health Info
Value in Health, Volume 26, Issue 11, S2 (December 2023)
Code
EE607
Topic
Economic Evaluation
Topic Subcategory
Cost-comparison, Effectiveness, Utility, Benefit Analysis
Disease
No Additional Disease & Conditions/Specialized Treatment Areas